arginine vasopressin has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inui, D; Nishimura, M; Ohto, J | 1 |
Badenhoop, K; Bergmann, L; Haak, T; Raab, C; Schmidt, A; Usadel, KH; Weidmann, E | 1 |
1 trial(s) available for arginine vasopressin and Precursor Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
The effects of interleukin-2 treatment on endothelin and the activation of the hypothalamic-pituitary-adrenal axis.
Topics: Adrenocorticotropic Hormone; Adult; Arginine Vasopressin; Endothelin-1; Endothelins; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Interleukin-2; Interleukin-6; Kidney Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Pituitary-Adrenal System; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Precursors; Stimulation, Chemical | 1999 |
1 other study(ies) available for arginine vasopressin and Precursor Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Massive melena due to arginine-vasopressin for septic shock in two pediatric patients.
Topics: Adolescent; Arginine Vasopressin; Child, Preschool; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid; Male; Melena; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Shock, Septic; Vasoconstrictor Agents | 2008 |